SELP and metabolic syndrome: Our results showed significative increases in the group with LC and MetS, emphasizing the significance of closely monitoring patients with metabolic diseases as increases in markers such as P-selectin and PSGL-1 raise the risks of developing atherosclerotic and vascular lesions.